Good afternoon
Steven R. Gerbsman, Principal of Gerbsman Partners, is pleased to announce the successful termination of a life science prohibitive real estate lease and the restructuring of accounts payable and intellectual property creditor issues.
The life science company needed to accomplish the above in order to obtain the necessary “bridge financing” to provide runway for a round of “expansion capital funding”.
Gerbsman Partners assisted by:
- creating a strategic plan to accomplish the successful termination of the prohibitive real estate lease
- negotiating with the real estate lessor and finalizing the termination of the lease
- negotiating with numerous accounts payable and creditor issues to restructure the balance sheet
Gerbsman Partners is the “innovator” in creating strategies to terminate or restructure prohibitive real estate leases and senior and sub-debt obligations, as well as creditor issues. To date, we have terminated or restructured over $810 million of such obligations for private and public companies, which has allowed the potential of returning the company to financial viability.
About Gerbsman Partners
Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in underperforming, undercapitalized and undervalued companies and their intellectual properties. Since 2001, Gerbsman Partners has successfully maximized the values of 120 companies in a wide and diverse spectrum of industries. In the process, GP has successfully restructured/terminated over $810 million of real estate executor contracts, creditor issues and equipment lease/sub-debt obligations, and has assisted in over $2.3 billion of financings, restructurings and M&A transactions.
Gerbsman Partners has offices and strategic alliances in Boston, New York, Washington DC, McLean VA, San Francisco, Orange County, Europe and Israel.
If appropriate, I am available to strategize and develop action plans for maximizing and monetizing value.
Best regards
Steve
Blog of Intellectual Capital 